Discover
AUPH
Aurinia Pharmaceuticals Inc.
15.37
1 x 15.30
1 x 15.75
bid
ask
-
0.08
0.52%
1 @ 04:00 PM
15.37 +0.00 (0.00%)
| Ytd | -3.64% | |
| 1y | 34.47% |
15.31
day range
15.59
10.34
52 week range
19.25
| Open | 15.50 | Prev Close | 15.45 | Low | 15.31 | High | 15.59 | Mkt Cap | 1.98B |
| Vol | 0.00 | Avg Vol | 1.48M | EPS | 1.02 | P/E | 15.07 | Forward P/E | 14.48 |
| Beta | 1.40 | Short Ratio | 4.70 | Inst. Own | 59.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 15.92 | 200-d Avg | 15.27 | 1yr Est | 17.00 |
| Income Statement | |||
| Total Revenue | 83.22M | ||
| Revenues (USD) | 83.22M | ||
| Cost of Revenue | 6.56M | ||
| Gross Profit | 76.67M | ||
| Operating Expenses | 30.32M | ||
| Research and Development Expense | 13.05M | ||
| Selling, General and Administrative Expense | 23.51M | ||
| Operating Income | 46.34M | ||
| Interest Expense | 948.00K | ||
| Income Tax Expense | 11.37M | ||
| Net Income | 37.41M | ||
| Net Income Common Stock | 37.41M | ||
| Net Income Common Stock (USD) | 37.41M | ||
| Consolidated Income | 37.41M | ||
| Earnings per Basic Share | 0.29 | ||
| Earnings per Basic Share (USD) | 0.29 | ||
| Earnings per Diluted Share | 0.28 | ||
| Earning Before Interest & Taxes (EBIT) | 49.73M | ||
| Earning Before Interest & Taxes (USD) | 49.73M | ||
| Weighted Average Shares | 130.08M | ||
| Weighted Average Shares Diluted | 133.53M | ||
| Balance Sheet | |||
| Cash and Equivalents | 179.83M | ||
| Cash and Equivalents (USD) | 179.83M | ||
| Investments | 263.29M | ||
| Investments Current | 263.29M | ||
| Trade and Non-Trade Receivables | 41.14M | ||
| Current Assets | 541.32M | ||
| Property, Plant & Equipment Net | 68.53M | ||
| Total Assets | 792.26M | ||
| Debt Current | 18.18M | ||
| Total Debt | 64.14M | ||
| Current Liabilities | 99.89M | ||
| Debt Non-Current | 45.95M | ||
| Total Liabilities | 177.40M | ||
| Accumulated Retained Earnings (Deficit) | -577.60M | ||
| Accumulated Other Comprehensive Income | -977.00K | ||
| Shareholders Equity | 614.86M | ||
| Shareholders Equity (USD) | 614.86M | ||
| Assets Non-Current | 250.94M | ||
| Total Debt (USD) | 64.14M | ||
| Deferred Revenue | 18.07M | ||
| Goodwill and Intangible Assets | 3.38M | ||
| Inventory | 45.15M | ||
| Liabilities Non-Current | 77.51M | ||
| Trade and Non-Trade Payables | 1.74M | ||
| Tax Assets | 178.94M | ||
| Tax Liabilities | 23.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.83M | ||
| Net Cash Flow from Financing | 4.81M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 138.82M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 5.21M | ||
| Issuance (Purchase) of Equity Shares | 20.09M | ||
| Issuance (Repayment) of Debt Securities | -3.40M | ||
| Net Cash Flow from Investing | 81.45M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 76.24M | ||
| Net Cash Flow from Operations | 52.57M | ||
| Share Based Compensation | 2.84M | ||